Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy for the Treatment of Metastatic Prostate Cancer

June 13, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search